{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:07:19Z","timestamp":1790654839619,"version":"4.1.0"},"reference-count":28,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.5551\/jat.56531","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T22:06:34Z","timestamp":1599689194000},"page":"604-610","source":"Crossref","is-referenced-by-count":17,"title":["The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease"],"prefix":"10.5551","volume":"28","author":[{"given":"Maria Pina","family":"Dore","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, University of Sassari"},{"name":"Baylor College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Portoghese","sequence":"additional","affiliation":[{"name":"Heart Surgery Unit, AOU Sassari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Mario","family":"Pes","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, University of Sassari"},{"name":"Sardinia Longevity Blue Zone Observatory"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mensah GA , Roth GA , Fuster V . The Global Burden of Cardiovascular Diseases and Risk Factors. 2020 and Beyond. JACC, 2019; 74: 2529- 2532","DOI":"10.1016\/j.jacc.2019.10.009"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Patel SA , Winkel M , Ali MK , Narayan KM , Mehta NK . Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med, 2015; 163: 245- 253","DOI":"10.7326\/M14-1753"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Mladenova I. Helicobacter pylori and cardiovascular disease: update 2019. Minerva Cardioangiol, 2019; 67: 425-432","DOI":"10.23736\/S0026-4725.19.04986-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Mendall MA , Goggin PM , Molineaux N , Levy J , Toosy T , Strachan D , Camm AJ , Northfield TC . Relation of Helicobacter pylori infection and coronary heart disease. BMJ, 1994; 71: 437- 439","DOI":"10.1136\/hrt.71.5.437"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ossei-Gerning N , Moayyedi P , Smith S , Braunholtz D , Wilson JI , Axon AT , Grant PJ . Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res, 1997; 35: 120- 124","DOI":"10.1016\/S0008-6363(97)00090-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Pasceri V , Cammarota G , Patti G , Cuoco L , Gasbarrini A , Grillo RL , Fedeli G , Gasbarrini G , Maseri A . Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation, 1998; 97: 1675- 1679","DOI":"10.1161\/01.CIR.97.17.1675"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Franceschi F , Sepulveda AR , Gasbarrini A , Pola P , Silveri NG , Gasbarrini G , Graham DY , Genta RM . Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation, 2002; 106: 430- 434","DOI":"10.1161\/01.CIR.0000024100.90140.19"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Dore MP , Sepulveda AR , Bacciu PP , Blasi F , Simula L , Marras L , Piccolo D , Cherchi GB , Graham DY , Realdi G . Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Dig Dis Sci, 2003; 48: 945- 951","DOI":"10.1023\/A:1023059815117"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Meloni L , Manca MR , Loddo I , Cioglia G , Cocco P , Schwartz A , Muntoni S , Muntoni S . Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease. J Inherit Metab Dis, 2008; 31: 412- 417","DOI":"10.1007\/s10545-008-0704-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Muntoni S , Batetta B , Dess\u00ec S , Muntoni S , Pani P . Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Eur J Epidemiol, 1992; 8 (Suppl 1): 48- 53","DOI":"10.1007\/BF00145349"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Luzzatto L , Arese P . Favism and glucose-6-phosphate dehydrogenase deficiency. N Engl J Med, 2018; 378: 60- 71","DOI":"10.1056\/NEJMra1708111"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Thomas JE , Kang S , Wyatt CJ , Kim FS , Mangelsdorff AD , Weigel FK . Glucose-6-phosphate dehydrogenase deficiency is associated with cardiovascular disease in U.S. military centers. Tex Heart Inst J, 2018; 45: 144- 150","DOI":"10.14503\/THIJ-16-6052"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Pes GM , Parodi G , Dore MP . Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: A propensity score-matched study. Atherosclerosis, 2019; 282: 148- 153","DOI":"10.1016\/j.atherosclerosis.2019.01.027"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zhao J , Zhang X , Guan T , Wang X , Zhang H , Zeng X , Dai Q , Wang Y , Zhou L , Ma X . The association between glucose-6-phosphate dehydrogenase deficiency and abnormal blood pressure among prepregnant reproductive-age Chinese females. Hypertens Res, 2019; 42: 75- 84","DOI":"10.1038\/s41440-018-0118-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Mach F , Baigent C , Catapano AL , Koskinas KC , Casula M , Badimon L , Chapman MJ , De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O ; ESC Scientific Document Group. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 2020; 41: 111- 188","DOI":"10.15829\/1560-4071-2020-3826"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Dore MP , Soro S , Niolu C , Longo NP , Bibb\u00f2 S , Manca A , Pes GM . Clinical features and natural history of idiopathic peptic ulcers: a retrospective case-control study. Scand J Gastroenterol, 2019; 54: 1315- 1321","DOI":"10.1080\/00365521.2019.1679247"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mosca A , Paleari R , Rosti E , Luzzana M , Barella S , Sollaino C , Galanello R . Simultaneous automated determination of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in whole blood. Eur J Clin Chem Clin Biochem, 1996; 34: 431- 438","DOI":"10.1515\/cclm.1996.34.5.431"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang J , Xiao QZ , Chen YM , Yi S , Liu D , Liu YH , Zhang CM , Wei XF , Zhou YQ , Zhong XM , Zhao CY , Xiong F , Wei XC , Xu XM . DNA hypermethylation and X chromosome inactivation are major determinants of phenotypic variation in women heterozygous for G6PD mutations. Blood Cells Mol Dis, 2014; 53: 241- 245","DOI":"10.1016\/j.bcmd.2014.06.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Pes GM , Errigo A , Bitti A , Dore MP . Effect of age, period and birth-cohort on the frequency of glucose-6-phosphate dehydrogenase deficiency in Sardinian adults. Ann Med, 2018; 50: 68- 73","DOI":"10.1080\/07853890.2017.1390247"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Xia X , Zhang L , Chi J, Li H, Liu X, Hu T, Li R, Guo Y, Zhang X, Wang H, Cai J, Li Y, Liu D, Cui Y, Zheng X, Flaker GC, Liao D, Hao H, Liu Z, Xu C . Helicobacter pylori Infection Impairs Endothelial Function Through an Exosome-Mediated Mechanism. J Am Heart Assoc, 2020; 9: e014120","DOI":"10.1161\/JAHA.119.014120"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sastre J , Pallard\u00f3 FV , Vi\u00f1a J . Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life, 2000; 49: 427- 435","DOI":"10.1080\/152165400410281"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Erden-Inal M , Sunal E , Kanbak G . Age-related changes in the glutathione redox system. Cell Biochem Funct, 2002; 20: 61- 66","DOI":"10.1002\/cbf.937"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Sekhar RV , Patel SG , Guthikonda AP , Reid M , Balasubramanyam A , Taffet GE , Jahoor F . Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr, 2011; 94: 847- 853","DOI":"10.3945\/ajcn.110.003483"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Parsanathan R , Jain SK . L-Cysteine in vitro can restore cellular glutathione and inhibits the expression of cell adhesion molecules in G6PD-deficient monocytes. Amino Acids, 2018; 50: 909- 921","DOI":"10.1007\/s00726-018-2559-x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Parsanathan R , Jain SK . Glucose-6-phosphate dehydrogenase deficiency increases cell adhesion molecules and activates human monocyte-endothelial cell adhesion: Protective role of l-cysteine. Arch Biochem Biophys, 2019; 663: 11- 21","DOI":"10.1016\/j.abb.2018.12.023"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Torregrossa AC , Aranke M , Bryan NS . Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly. J Geriatr Cardiol, 2011; 8: 230- 242","DOI":"10.3724\/SP.J.1263.2011.00230"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Schwartz AG , Pashko LL . Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity. Ageing Res Rev, 2004; 3: 171- 187","DOI":"10.1016\/j.arr.2003.05.001"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Manganelli G , Masullo U , Passarelli S , Filosa S . Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc Hematol Disord Drug Targets, 2013; 13: 73- 82","DOI":"10.2174\/1871529X11313010008"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/28\/6\/28_56531\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T04:42:15Z","timestamp":1622868135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/28\/6\/28_56531\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.56531","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}